Adult Asthma: Individualizing and Optimizing Care CME

Bradley E. Chipps, MD Author Information and Disclosures

Release Date: June 13, 2008; Valid for credit through June 13, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

This CME activity was designed as a Test and Teach program for release on Medscape.

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the educational content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME Activity

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 PCME
Merck
Learning Objectives
Upon completion of this activity, participants should be able to:
  • Describe why heterogeneous responses to therapy occur in adults with asthma
  • Demonstrate the ability to adjust therapy as indicated to attain the best disease control in an adult with asthma
  • Consider diagnostic and treatment issues associated with co-morbid conditions
Author Disclosures

Bradley E. Chipps, MD
Disclosure: Grants for Clinical Research: Aventis, Genentech, Astra Zeneca, GSK, Novartis, Schering, Sepracor, Merck; Grants for Educational Activities: Alcon, Aventis, Genentech, AstraZeneca, GSK, Novartis; Advisor for Consult: Alcon, Aventis, Genentech, AstraZeneca, GSK, MedPoint, Novartis, Schering, Sepracor, Merck; Speakers Bureau: Alcon, Aventis, Genentech, AstraZeneca, Boehringer, GSK, MedPoint, Novartis, Pfizer, Schering, Sepracor, Merck.
 
PCME
This activity is sponsored by The Potomac Center for Medical Education.

The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

PCME designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.